相关实验视频

Updated: Jun 20, 2025

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

描述瘤微环境及其与胃癌中cDC1相关基因表达的相关性

Song-Hee Han¹, Mi Ha Ju¹

¹Department of Pathology Dong-A University College of Medicine, Busan, Republic of Korea.

Journal of immunology research

|July 17, 2024

概括

较高的cDC1相关基因特征表明胃癌 (GC) 的存活率较差. 这种特征与免疫抑制性瘤微环境相关,突出显示了cDC1s.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
基因组学就是基因组学.

背景情况:

瘤微环境显著影响癌症的进展和患者的结果.
1型常规树突细胞 (cDC1s) 在抗瘤免疫中起着至关重要的作用.
了解cDC1相关基因在胃癌 (GC) 中的作用,对于开发有效疗法至关重要.

研究的目的:

在胃癌中研究cDC1相关基因特征的预后价值.
探索cDC1特征与GC中的瘤免疫微环境之间的关联.
在GC中识别cDC1介导的免疫反应中的潜在治疗点.

主要方法:

分析来自TCGA-STAD和GEO数据集的RNA-seq数据.
与cDC1相关的基因特征的定义和分层,分为高表达和低表达组.
对于致癌途径的基因组变异分析 (GSVA) 和统计建模 (Kaplan-Meier,Cox模型).

主要成果:

较高的cDC1相关基因特征与GC患者的整体和无病生存率较差有关.
在高和低签名组之间观察到CD8+T细胞透和细胞毒性活性的显著差异.
cDC1的特征与免疫检查点蛋白和瘤性途径的增加相关,表明免疫抑制性瘤微环境.

结论:

与cDC1相关的基因特征显示了作为GC的预后生物标志物的潜力.
cDC1s在塑造GC瘤微环境和影响患者预后方面至关重要.
这些发现可能会为针对GC免疫微环境的新型治疗策略提供信息.

更多相关视频

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

相关概念视频

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...